Alluvi Reta Pen | Alluvi Bpc-157 & Tb-500

Alluvi Reta Pen, Alluvi Bpc-157 & Tb-500, Alluvi BPC-157 & TB-500 40mg (R&D Only) is a specialized research formulation combining two peptides of interest in regenerative science: 20mg BPC-157 and 20mg TB-500. Packaged in a pre-filled research pen, it is intended solely for laboratory and experimental use. It is not approved for medical or veterinary applications and is explicitly labeled for research and development purposes only.

Alluvi Reta Pen | Key Features

• Formulation: 40mg total, evenly split between BPC-157 and TB-500.
• Delivery: Pre-filled research pen for precise dosing in controlled experiments.
• Quality Control: Sealed batches to maintain compound integrity.
• Storage: Refrigeration required at 2–8°C; freezing must be avoided.
• Shipping: Cold packs included to preserve peptide stability during transit.

Alluvi Reta Pen | Research Applications

• Peptide stability studies: Evaluating how BPC-157 and TB-500 maintain integrity under different conditions.
• Formulation testing: Assessing delivery mechanisms and compound compatibility.
• Mechanistic exploration: Investigating biochemical pathways related to tissue repair, angiogenesis, and cellular migration.
• Synergistic effects: Studying how the combination of BPC-157 and TB-500 may influence regenerative processes in experimental models.

Clinical Context

Although both peptides are of interest in regenerative medicine research, neither is approved for clinical use.

• BPC-157: Derived from a protein in gastric juice, studied for potential roles in inflammation modulation and tissue healing.
• TB-500: A synthetic fragment of thymosin beta-4, investigated for possible effects on wound recovery and vascular growth. Current findings are preliminary, and any therapeutic claims remain unverified. Their use is restricted to laboratory settings, with no established safety or efficacy data for human application.

Considerations

• Ethical compliance: Researchers must adhere to institutional and regulatory guidelines.
• Safety protocols: Proper handling and storage are essential to maintain compound integrity.
• Limitations: Results from laboratory studies cannot be extrapolated to clinical practice.
• Legal restrictions: Distribution and use are limited to R&D contexts, not for consumption.